Nipro Overview
- Founded
- 1954

- Status
- Public
- Employees
- 33,915

- Stock Symbol
- 8086

- Investments
- 22
- Share Price
- $11.63
- (As of Friday Closing)
Nipro General Information
Description
Nipro Corp develops medical devices, most of which are related to dialysis and artificial organs. The firm operates in four segments: medical, pharmaceutical, glass, and other. The medical segment contributes the majority of revenue. It sells products related to injections, infusions, artificial organs, and cell cultures, as well as medical equipment for renal treatment, diabetes, and generic drugs. Renal products contribute the largest proportion of sales within the medical segment. The pharmaceutical segment manufactures pharmaceuticals, including oral drugs and injectables, which are supplied to pharmaceutical companies in Japan. The glass business sells glass products used for medical applications, such as vials and syringes. Nipro generates the majority of its revenue in Japan.
Contact Information
- 3-9-3 Honjo-Nishi Kita-ku
- Osaka, 531-8510
- Japan
Nipro Stock Performance
(As of Friday Closing)
Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
---|---|---|---|---|---|---|
$11.63 | $11.84 | $8.55 - $12.94 | $1.9B | 163M | 564K | -$0.72 |
Nipro Financials Summary
In Thousands, USD |
TTM 30-Sep-2020 | FY 2020 31-Mar-2020 | FY 2019 31-Mar-2019 | FY 2018 31-Mar-2018 |
---|---|---|---|---|
EV | 6,394,565 | 6,174,147 | 5,982,270 | 5,906,481 |
Revenue | 4,099,234 | 4,069,768 | 3,845,828 | 3,566,859 |
EBITDA | 322,216 | 315,214 | 562,697 | 505,065 |
Net Income | (117,701) | (112,947) | 109,458 | 106,709 |
Total Assets | 8,406,270 | 7,697,247 | 7,628,290 | 7,776,866 |
Total Debt | 5,627,495 | 5,008,834 | 4,897,813 | 4,935,018 |
Nipro Comparisons
Industry
00000000
00000000
PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.
Request a free trialNipro Competitors (17)
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Fresenius Kabi | Corporate Backed or Acquired | Bad Homburg, Germany | 0000 | |||
000000000000000 | Corporation | Brentford, United Kingdom | 00000 | 00000000000 | ||
0000 0000000000000 | Corporate Backed or Acquired | Petach Tikva, Israel | 00000 | 00000 | 00000000000 | 00000 |
000000000 0000000 | Corporation | Bad Homburg, Germany | 000000 | 00000000 | ||
00000000 | Corporation | Basel, Switzerland | 000000 | 000000000000 |
Nipro Executive Team (4)
Name | Title | Board Seat | Contact Info |
---|---|---|---|
Yoshihiko Sano | President and Representative Director | ||
Goichi Miyazumi | President | ||
Toshiaki Masuda | Managing Director |
Nipro Signals
Growth Rate

Growth

Size Multiple


Key Data Points
Twitter Followers
5.5k

Similarweb Unique Visitors
15.0K

Majestic Referring Domains
314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialNipro Investments & Acquisitions (22)
Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
---|---|---|---|---|---|
000000 0000000 | 28-Oct-2020 | 0000 00000 | 00.00 | Therapeutic Devices | 00000000 000000 |
0000000 000 | 03-Mar-2020 | 000000000000000000 | Specialty Chemicals | 000000 00000000 | |
00 00000000 | 18-Jan-2017 | 00000 00000 00 | 00.000 | Biotechnology | |
000000000 | 31-Oct-2015 | 000000000000000000 | 0000 | Diagnostic Equipment | 000000000 0000 |
Atonarp | 12-Aug-2014 | Early Stage VC | 000 | Electronic Equipment and Instruments |
Nipro Subsidiaries (7)
Company Name | Industry | Location | Founded |
---|---|---|---|
Dimesol USA | Specialty Chemicals | Lewisberry, PA | 2016 |
0000 0000000 & 000 | Biotechnology | Aoba-ku, Japan | 0000 |
000000000 | Diagnostic Equipment | Burlington, MA | 0000 |
00000 000000 | Acquirer | Mechelen, Belgium | 0000 |
0.0. 00000 | Pharmaceuticals | Lancaster, NH | 0000 |
Nipro Exits (3)
Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
---|---|---|---|---|---|
0000000 000000 | 15-Mar-2010 | 000000000000000000 | 00000 | Completed |
|
000000000 | 07-Oct-2008 | 00000 00000 00 | 00.000 | Completed |
|
Bipha | 01-Feb-2001 | Secondary Transaction - Private | Completed |